Human health

EasyNAT® Influenza A/B

Rapid detection kit for Influenza A/B

Request a quote
This automated in vitro nucleic acid amplification test is used for rapid qualitative detection and differentiation of influenza A and B virus RNA in oropharyngeal (throat) swabs taken from individuals presenting signs and/or symptoms of respiratory infection in the context of clinical and epidemiological risk factors.
The entire process is integrated into the cartridge (lysis, extraction, purification, amplification) to limit any risk of contamination Rapid test: results in 40 min

Indication

This EasyNAT rapid screening test is used for the in vitro qualitative diagnosis of Influenza A and B virus nucleic acids.

Principle

Cross priming amplification

Withdrawal

Oropharyngeal swabs, nasopharyngeal swabs.

Target sequences

influenza A (M gene, PB2 gene and PA gene) and influenza B (M gene, NEP gene and NP gene). – IC: GAPDH

Storage (t°C)

2~8 °C

Catalog number

U20206

Packaging

20 tests

Manufacturer

USTAR Biotechnologies

Country

China

Ask for a quote

If you have any questions or would like to discuss our services, we invite you to contact us. Our team is always available to assist you, 7 days a week, and is committed to responding to all your requests in less than 24 hours.

Please enable JavaScript in your browser to complete this form.

Related products

Human health

Respi+ (FluA/ FluB/ COVID/ RSV)

Kit for the qualitative detection and simultaneous differentiation of influenza A, influenza B, SARS-CoV-2 and RSV RNA.

  • RT-PCR kits
  • Respiratory infections
Read more

Human health

HybriSpot – Panel on tick-borne infections

Detection kit for major tick-borne pathogens

  • Hybridization / genotyping
  • Test panel
Read more

Human health

HybriSpot – Respiratory Panel

Detection kit for major pathogens causing acute respiratory infections

  • Hybridization / genotyping
  • Sexually transmitted infections
Read more

Any questions?

At EasyNAT® Influenza A/B, we understand the regulatory challenges faced by our French customers. We offer support in your accreditation process, including assistance in preparing the files needed to validate new techniques. Our approach is to provide local support, with flexibility and adaptability.

We are ISO 13485:2016 certified, demonstrating our commitment to the highest international standards for medical devices. What’s more, all our products are designed and manufactured in France, guaranteeing a high level of expertise and quality control.

We maintain a strategic buffer stock for all our distributed products, minimizing the risk of stock-outs. Should the need arise, our Lyon-based after-sales service is ready to react quickly to ensure your business continues uninterrupted.

Our logistics are optimized for rapid delivery throughout France and internationally. With efficient processes and a well-established distribution network, we ensure that your orders reach you in the shortest possible time.

Navigation

Legal

Contact

  • 205, rue des frères Lumière 69970 CHAPONNAY
    France
  • +33 (0)4 37 57 00 54
  • Linkedin

© 2024 Appolon Bioteck - passionately crafted by Nexoka